Pathogenic microorganism | Model | The role of HIF-1α in infections | References |
---|---|---|---|
Bacteria | |||
Escherichia coli | UTI model | Promotes the production of NO and antimicrobial peptides | [71] |
Pseudomonas aeruginosa | Keratitis model | Enhances the activation of inflammatory cells, production of antimicrobial peptides, and ability to kill bacteria | [72] |
Klebsiella pneumoniae | Pneumonia model | HIF-1α is a susceptibility factor for bacterial invasion during pneumonia | [73] |
Clostridium difficile | Ileal loop model | Protects the intestinal mucosa from C difficile toxins | [74] |
Staphylococcus aureus | Kidney abscesses model | Participation in abscess formation | [75] |
Streptococcus pneumoniae | Pneumonia model | No significant impact | [76] |
Salmonella Typhimurium | Salmonella infection model | No significant impact | [77] |
Viruses | |||
BKV | Kidney tissue samples | bind the BKV promoter and enhance BKV replication | [78] |
RSV | Primary human small alveolar epithelial cells | RSV replication and the glycolytic pathway | [79] |
DENV | Primary monocytes | Enhance antibody‐dependent DENV infection in monocytic cells | [80] |
HBV | Liver-derived cell | Increases HBV RNA transcript levels, core protein levels, cytoplasmic localization of core protein, and replication of the HBV | [81] |
VACV | HEK293T cell | Involved in virus-induced hypoxic responses | [61] |
SARS-CoV-2 | PBMCs | Virus replication and monocyte cytokine production | [82] |
Fungi | |||
Aspergillus fumigatus | A549 cells and mouse airway cells | Upregulation induces pro-inflammatory factors | [70] |
Candida albicans | CA-colonized mice | Inhibits Candida albicans colonization | [69] |